Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2019 Nov;28(11):908-915.
doi: 10.1136/bmjqs-2019-009420. Epub 2019 Aug 7.

Automated detection of wrong-drug prescribing errors

Affiliations
Observational Study

Automated detection of wrong-drug prescribing errors

Bruce L Lambert et al. BMJ Qual Saf. 2019 Nov.

Abstract

Background: To assess the specificity of an algorithm designed to detect look-alike/sound-alike (LASA) medication prescribing errors in electronic health record (EHR) data.

Setting: Urban, academic medical centre, comprising a 495-bed hospital and outpatient clinic running on the Cerner EHR. We extracted 8 years of medication orders and diagnostic claims. We licensed a database of medication indications, refined it and merged it with the medication data. We developed an algorithm that triggered for LASA errors based on name similarity, the frequency with which a patient received a medication and whether the medication was justified by a diagnostic claim. We stratified triggers by similarity. Two clinicians reviewed a sample of charts for the presence of a true error, with disagreements resolved by a third reviewer. We computed specificity, positive predictive value (PPV) and yield.

Results: The algorithm analysed 488 481 orders and generated 2404 triggers (0.5% rate). Clinicians reviewed 506 cases and confirmed the presence of 61 errors, for an overall PPV of 12.1% (95% CI 10.7% to 13.5%). It was not possible to measure sensitivity or the false-negative rate. The specificity of the algorithm varied as a function of name similarity and whether the intended and dispensed drugs shared the same route of administration.

Conclusion: Automated detection of LASA medication errors is feasible and can reveal errors not currently detected by other means. Real-time error detection is not possible with the current system, the main barrier being the real-time availability of accurate diagnostic information. Further development should replicate this analysis in other health systems and on a larger set of medications and should decrease clinician time spent reviewing false-positive triggers by increasing specificity.

Keywords: decision support, computerized; medication safety; patient safety; quality improvement.

PubMed Disclaimer

Conflict of interest statement

Competing interests: BLL has an ownership interest in two companies that provide software and consulting services related to the detection and prevention of drug name confusions. BLL’s companies had no role in the conduct of the studies described here.

Figures

Figure 1
Figure 1
Pseudo-code for the error detection algorithm.
Figure 2
Figure 2
Number of alerts and positive predictive value as a function of similarity level.

References

    1. Cina JL, Gandhi TK, Churchill W, et al. . How many hospital pharmacy medication dispensing errors go undetected? Jt Comm J Qual Patient Saf 2006;32:73–80. 10.1016/S1553-7250(06)32010-7 - DOI - PubMed
    1. Flynn EA, Barker KN, Carnahan BJ. National observational study of prescription dispensing accuracy and safety in 50 pharmacies. J Am Pharm Assoc 2003;43:191–200. and 10.1331/108658003321480731 - DOI - PubMed
    1. Barker KN, Flynn EA, Pepper GA, et al. . Medication errors observed in 36 health care facilities. Arch Intern Med 2002;162:1897–903. 10.1001/archinte.162.16.1897 - DOI - PubMed
    1. Hicks RW. Becker SC and Cousins DD eds. Medmarx data report. A report on the relationship of drug names and medication errors in response to the Institute of Medicine’s call for action. Rockville, MD: US Pharmacopeia, 2008.
    1. Edward M, Quinn JA, Mukherjee S, et al. . Gadodiamide contrast agent ‘activates’ fibroblasts: a possible cause of nephrogenic systemic fibrosis. J Pathol 2008;214:584–93. 10.1002/path.2311 - DOI - PubMed

Publication types